PanPath BV is a company that specializes in the development and delivery of high-quality diagnostic products, specifically in the field of molecular pathology. The company's core business involves the design, manufacture, and distribution of Fluorescence In Situ Hybridization (FISH) and In Situ Hybridization (ISH) assays, which are used to detect genetic abnormalities, such as gene amplifications and rearrangements, in formalin-fixed paraffin-embedded tissue sections or fixed cytological specimens. PanPath's products, including the REMBRANDT series, are used in research and diagnostic applications, including the detection of HER2 amplification, RET break apart, and EBER expression, among others. The company offers customized FISH assays tailored to specific research projects and collaborates with scientists worldwide to ensure the quality and reliability of its products.

Looking for Channel Partners in: